Clinical trial
A Multi-Center, Observational Study to Evaluate the Efficacy and Safety of Enavogliflozin in Patients With Type II Diabetes Mellitus Accompanied by Hypertension or Dyslipidemia
NCT06647888 is registered in ClinicalTrials.gov with Daewoong Pharmaceutical Co. LTD. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center, Observational Study to Evaluate the Efficacy and Safety of Enavogliflozin in Patients With Type II Diabetes Mellitus Accompanied by Hypertension or Dyslipidemia
- Lead sponsor
- Daewoong Pharmaceutical Co. LTD.
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 3, 2024
- Completion date
- June 30, 2026
- Enrollment
- 12,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.